Author

Anderly C. Chüeh

Monash UniversityORCID 0000-0003-1140-5516Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Lan K. NguyeniD· 2 shared Roger J. DalyiD· 2 shared Sung‐Young ShiniD· 2 shared Andrew M. EllisdoniD· 1 shared Bao V. NguyeniD· 1 shared Changyuan HuiD· 1 shared Charles Bayly-JonesiD· 1 shared David R. CroucheriD· 1 shared

Activity by Year

2021-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Lan K. NguyenORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyNature CommunicationsPeer-reviewedFeb 21, 2025

Feed-forward stimulation of CAMK2 by the oncogenic pseudokinase PEAK1 generates a therapeutically "actionable" signalling axis in triple negative breast cancer

Xue Yang, Xiuquan Ma, Tianyue Zhao…·Roger J. Daly

This study identifies a novel feed-forward signalling axis between PEAK1 and CAMK2 in TNBC, showing that targeting CAMK2 can inhibit PEAK1-driven oncogenic processes.

10 citations

humanproteomics

𝕏 PostBluesky

Systems BiologybioRxivPreprintNov 3, 2021

Integrative Modelling of Signalling Network Dynamics Identifies Cell Type-selective Therapeutic Strategies for FGFR4-driven Cancers

Sung‐Young Shin, Nicole J. Chew, Milad Ghomlaghi…·Roger J. Daly

The paper develops a computational model of FGFR4 signalling to identify cell type-selective combination therapies for FGFR4-driven cancers, revealing AKT and ERK reactivation as key resistance mechanisms.

3 citations

humanbulk RNA-seq

𝕏 PostBluesky